Intervention Review

You have free access to this content

Antibiotic therapy for the treatment of methicillin-resistant Staphylococcus aureus (MRSA) infections in surgical wounds

  1. Kurinchi Selvan Gurusamy1,*,
  2. Rahul Koti1,
  3. Clare D Toon2,
  4. Peter Wilson3,
  5. Brian R Davidson1

Editorial Group: Cochrane Wounds Group

Published Online: 20 AUG 2013

Assessed as up-to-date: 21 FEB 2013

DOI: 10.1002/14651858.CD009726.pub2


How to Cite

Gurusamy KS, Koti R, Toon CD, Wilson P, Davidson BR. Antibiotic therapy for the treatment of methicillin-resistant Staphylococcus aureus (MRSA) infections in surgical wounds. Cochrane Database of Systematic Reviews 2013, Issue 8. Art. No.: CD009726. DOI: 10.1002/14651858.CD009726.pub2.

Author Information

  1. 1

    Royal Free Campus, UCL Medical School, Department of Surgery, London, UK

  2. 2

    West Sussex County Council, Public Health, Chichester, West Sussex, UK

  3. 3

    University College London Hospitals, Department of Microbiology & Virology, London, UK

*Kurinchi Selvan Gurusamy, Department of Surgery, Royal Free Campus, UCL Medical School, Royal Free Hospital,, Rowland Hill Street, London, NW3 2PF, UK. kurinchi2k@hotmail.com.

Publication History

  1. Publication Status: New
  2. Published Online: 20 AUG 2013

SEARCH

References

References to studies included in this review

  1. References to studies included in this review
  2. References to studies excluded from this review
  3. Additional references
Weigelt 2004 {published data only}

References to studies excluded from this review

  1. References to studies included in this review
  2. References to studies excluded from this review
  3. Additional references
Jacqueline 2011 {published data only}
  • Jacqueline C, Amador G, Desessard C, Le Mabecque V, Miegeville AF, Caillon J, et al. Assessment of linezolid, vancomycin, and rifampicin as monotherapy in comparison with combination of linezolid/rifampicin and vancomycin/rifampicin in the treatment of methicillin-resistant Staphylococcus aureus acute osteomyelitis. Clinical Microbiology and Infection 2011;17(Supplement S4):S428.
Lucasti 2008 {published data only}
  • Lucasti C, Jasovich A, Umeh O, Jiang J, Kaniga K, Friedland I. Efficacy and tolerability of IV doripenem versus meropenem in adults with complicated intra-abdominal infection: a phase III, prospective, multicenter, randomized, double-blind, noninferiority study. Clinical Therapeutics 2008;30(5):868-83.
Philpott 2003 {published data only}
  • Philpott-Howard J, Burroughs A, Fisher N, Hastings M, Kibbler C, Mutimer D, et al. Piperacillin-tazobactam versus ciprofloxacin plus amoxicillin in the treatment of infective episodes after liver transplantation. Journal of Antimicrobial Chemotherapy 2003;52:993-1000.
Van Laethem 1988 {published data only}
  • Van Laethem Y, Hermans P, De Wit S, Goosens H, Clumeck N. Teicoplanin compared with vancomycin in methicillin-resistant Staphylococcus aureus infections: preliminary results. Journal of Antimicrobial Chemotherapy 1988;21(Supplement A):81-7.

Additional references

  1. References to studies included in this review
  2. References to studies excluded from this review
  3. Additional references
Barber 1961
Chemaly 2010
  • Chemaly RF, Hachem RY, Husni RN, Bahna B, Rjaili GA, Waked A, et al. Characteristics and outcomes of methicillin-resistant Staphylococcus aureus surgical-site infections in patients with cancer: a case-control study. Annals of Surgical Oncology 2010;17(6):1499-506.
Deeks 2011
  • Deeks JJ, Higgins JPT, Altman DG, on behalf of the Cochrane Statistical Methods Group and the Cochrane Bias Methods Group (Editors). Chapter 9:  Analysing data and undertaking meta-analyses. In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane-handbook.org.
DeMets 1987
DerSimonian 1986
Donlan 2002
ECDC 2009a
  • ECDC. European Centre for Disease Prevention and Control. Annual epidemiological report on communicable diseases in Europe. http://www.ecdc.europa.eu/en/publications/Publications/0910_SUR_Annual_Epidemiological_Report_on_Communicable_Diseases_in_Europe.pdf 2009 (accessed on 17 June 2011).
ECDC 2009b
  • ECDC. European Centre for Disease Prevention and Control. The bacterial challenge: Time to react. A call to narrow the gap between multi-drug resistant bacteria in the EU and the development of new anti-bacterial agents. http://www.ecdc.europa.eu/en/publications/Publications/0909_TER_The_Bacterial_Challenge_Time_to_React.pdf 2009 (accessed on 17 June 2011).
Egger 1997
  • Egger M, Davey SG, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ 1997;315(7109):629-34.
Fraser 2010
  • Fraser S, Brady R, Graham C, Paterson-Brown S, Gibb A. Methicillin-resistant Staphylococcus aureus in surgical patients: identification of high-risk populations for the development of targeted screening programmes. Annals of the Royal College of Surgeons of England 2010;92(4):311-5.
Gurusamy 2009
Gurusamy 2013a
  • Gurusamy KS, Koti R, Toon C, Wilson P, Davidson BR. Antibiotic therapy for the treatment of methicillin-resistant Staphylococcus aureus (MRSA) in non-surgical wounds. Cochrane Database of Systematic Reviews In press.
Gurusamy 2013b
  • Gurusamy KS, Koti R, Wilson P, Davidson BR. Antibiotic prophylaxis for the prevention of methicillin-resistant Staphylococcus aureus (MRSA) related complications in surgical patients. Cochrane Database of Systematic Reviews In press.
Harbarth 2008
  • Harbarth S, Huttner B, Gervaz P, Fankhauser C, Chraiti MN, Schrenzel J, et al. Risk factors for methicillin-resistant Staphylococcus aureus surgical site infection. Infection Control and Hospital Epidemiology 2008;29(9):890-3.
Higgins 2002
Higgins 2011a
  • Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane-handbook.org.
Higgins 2011b
  • Higgins JPT, Altman DG, on behalf of the Cochrane Statistical Methods Group and the Cochrane Bias Methods Group (Editors). Chapter 8:  Assessing risk of bias in included studies. In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane-handbook.org.
Higgins 2011c
  • Higgins JPT, Deeks JJ and Altman DG on behalf of the Cochrane Statistical Methods Group (Editors). Chapter 16: Special topics in statistics. In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane-handbook.org.
Horan 1992
  • Horan TC, Gaynes RP, Martone WJ, Jarvis WR, Emori TG. CDC definitions of nosocomial surgical site infections, 1992: a modification of CDC definitions of surgical wound infections. Infection Control and Hospital Epidemiology 1992;13(10):606-8.
ICH-GCP 1996
  • International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use. Code of Federal Regulation & ICH Guidelines. Media: Parexel Barnett, 1996.
Jevons 1961
  • Jevons PM. “Celbenin” - resistant staphylococci. British Medical Journal 1961;1(5219):124-5.
Kallen 2010
  • Kallen AJ, Mu Y, Bulens S, Reingold A, Petit S, Gershman K, et al. Health care-associated invasive MRSA infections, 2005-2008. JAMA 2010;304(6):641-8.
Kang 2012
  • Kang CI, Song JH, Ko KS, Chung DR, Peck KR. Clinical features and outcomes of Staphylococcus aureus infections in non-neutropenic cancer patients. Supportive Care in Cancer 2012;20(3):483-8.
Kaye 2008
  • Kaye KS, Anderson DJ, Choi Y, Link K, Thacker P, Sexton DJ. The deadly toll of invasive methicillin-resistant Staphylococcus aureus infection in community hospitals. Clinical Infectious Diseases 2008;46(10):1568-77.
Keel 2011
  • Keel RA, Schaeftlein A, Kloft C, Pope JS, Knauft RF, Muhlebach M, et al. Pharmacokinetics of intravenous and oral linezolid in adults with cystic fibrosis. Antimicrobial Agents and Chemotherapy 2011;55(7):3393-8.
Kjaergard 2001
  • Kjaergard LL, Villumsen J, Gluud C. Reported methodologic quality and discrepancies between large and small randomized trials in meta-analyses. Annals of Internal Medicine 2001;135(11):982-9.
Klimek 1976
  • Klimek JJ, Marsik FJ, Bartlett RC, Weir B, Shea P, Quintiliani R. Clinical, epidemiologic and bacteriologic observations of an outbreak of methicillin-resistant Staphylococcus aureus at a large community hospital. American Journal of Medicine 1976;61(3):340-5.
Knox 1961
  • Knox R, Smith JT. The nature of penicillin resistance in staphylococci. Lancet 1961;2(7201):520-2.
Kuehnert 2005
  • Kuehnert MJ, Hill HA, Kupronis BA, Tokars JI, Solomon SL, Jernigan DB. Methicillin-resistant–Staphylococcus aureus hospitalizations, United States. Emerging Infectious Diseases 2005;11(6):868-72.
Lamagni 2011
  • Lamagni TL, Potz N, Powell D, Pebody R, Wilson J, Duckworth G. Mortality in patients with meticillin-resistant Staphylococcus aureus bacteraemia, England 2004-2005. Journal of Hospital Infection 2011;77(1):16-20.
Lefebvre 2011
  • Lefebvre C, Manheimer E, Glanville J, on behalf of the Cochrane Information Retrieval Methods Group. Chapter 6: Searching for studies. In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane-handbook.org.
Lewis 2011
  • Lewis T, Chaudhry R, Nightingale P, Lambert P, Das I. Methicillin-resistant Staphylococcus aureus bacteremia: epidemiology, outcome, and laboratory characteristics in a tertiary referral center in the UK. International Journal of Infectious Diseases 2011;15(2):e131-5.
Liu 2011
  • Liu C, Bayer A, Cosgrove SE, Daum RS, Fridkin SK, Gorwitz RJ, et al. Clinical practice guidelines by the Infectious Diseases Society of America for the treatment of methicillin-resistant Staphylococcus aureus infections in adults and children: executive summary. Clinical Infectious Diseases 2011;52(3):285-92.
Loeb 2003
  • Loeb MB, Main C, Eady A, Walkers-Dilks C. Antimicrobial drugs for treating methicillin-resistant Staphylococcus aureus colonization. Cochrane Database of Systematic Reviews 2003, Issue 4. [DOI: 10.1002/14651858.CD003340]
Macaskill 2001
Melzer 2013
  • Melzer M, Welch C. Outcomes in UK patients with hospital-acquired bacteraemia and the risk of catheter-associated urinary tract infections. Postgraduate Medical Journal 2013;Mar 21:Epub ahead of print. [DOI: 10.1136/postgradmedj-2012-131393]
Moher 1998
  • Moher D, Pham B, Jones A, Cook DJ, Jadad AR, Moher M, et al. Does quality of reports of randomised trials affect estimates of intervention efficacy reported in meta-analyses?. Lancet 1998;352(9128):609-13.
Newell 1992
O'Toole 1970
  • O'Toole RD, Drew WL, Dahlgren BJ, Beaty HN. An outbreak of methicillin-resistant Staphylococcus aureus infection. Observations in hospital and nursing home. JAMA 1970;213(2):257-63.
OED 2011
  • OED. Oxford English Dictionary. The definitive record of the English language. http://www.oed.com/ 2011 (accessed on 7th April, 2011).
Otter 2011
  • Otter JA, French GL. Community-associated meticillin-resistant Staphylococcus aureus strains as a cause of healthcare-associated infection. Journal of Hospital Infection 2011;79(3):189-93.
Parmar 1998
Reddy 2007
  • Reddy SL, Grayson AD, Smith G, Warwick R, Chalmers JA. Methicillin resistant Staphylococcus aureus infections following cardiac surgery: incidence, impact and identifying adverse outcome traits. European Journal of Cardio-Thoracic Surgery 2007;32(1):113-7.
RevMan 2011
  • The Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager (RevMan). 5.1. Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration, 2011.
Ridgeway 2005
  • Ridgeway S, Wilson J, Charlet A, Kafatos G, Pearson A, Coello R. Infection of the surgical site after arthroplasty of the hip. Journal of Bone and Joint Surgery. British Volume 2005;87(6):844-50.
Sanchez 2013
  • Sanchez CJ Jr, Mende K, Beckius ML, Akers KS, Romano DR, Wenke JC, et al. Biofilm formation by clinical isolates and the implications in chronic infections. BMC Infectious Diseases 2013;13:47.
Sanjay 2010
  • Sanjay P, Fawzi A, Kulli C, Polignano FM, Tait IS. Impact of methicillin-resistant Staphylococcus Aureus (MRSA) infection on patient outcome after pancreatoduodenectomy (PD)--a cause for concern?. Pancreas 2010;39(8):1211-4.
Schulz 1995
  • Schulz KF, Chalmers I, Hayes RJ, Altman DG. Empirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled trials. JAMA 1995;273(5):408-12.
Schunemann 2009
  • Schunemann H, Brożek J, Oxman A, editors. Grade handbook for grading quality of evidence and strength of recommendation. Version 3.2 [updated March 2009]. The Grade Working Group, 2009. Available from http://www.Cc-ims.Net/gradepro.
Schünemann 2011
  • Schünemann HJ, Oxman AD, Higgins JPT, Vist GE, Glasziou P, Guyatt GH (editors) on behalf of the Cochrane Applicability and Recommendations Methods Group and the Cochrane Statistical Methods Group. Chapter 11:  Presenting results and ‘Summary of findings’ tables. In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane-handbook.org.
Shukla 2009
  • Shukla S, Nixon M, Acharya M, Korim MT, Pandey R. Incidence of MRSA surgical-site infection in MRSA carriers in an orthopaedic trauma unit. Journal of Bone and Joint Surgery. British Volume 2009;91(2):225-8.
SIGN 2011
  • Scottish Intercollegiate Guidelines Network (SIGN). Search filters. http://www.sign.ac.uk/methodology/filters.html#random 2011.
Skov 2005
  • Skov R, Kolmos HJ, Peltonen R, Vuopio-Varkila J, Hardardottir H, Gudlaugsson O, et al. MRSA infections increasing in the Nordic countries. Eurosurveillance 2005;10(31):http://www.eurosurveillance.org/ViewArticle.aspx?ArticleId=2765.
Vinh 2009
  • Vinh DC, Rubinstein E. Linezolid: a review of safety and tolerability. Journal of Infection 2009;59(Supplement 1):S59-74.
Wang 2010
  • Wang JT, Wang JL, Fang CT, Chie WC, Lai MS, Lauderdale TL, et al. Risk factors for mortality of nosocomial methicillin-resistant Staphylococcus aureus (MRSA) bloodstream infection: with investigation of the potential role of community-associated MRSA strains. Journal of Infection 2010;61(6):449-57.
Watanabe 2008
  • Watanabe A, Kohnoe S, Shimabukuro R, Yamanaka T, Iso Y, Baba H, et al. Risk factors associated with surgical site infection in upper and lower gastrointestinal surgery. Surgery Today 2008;38(5):404-12.
Wood 2008
  • Wood L, Egger M, Gluud LL, Schulz KF, Jüni P, Altman GD, et al. Empirical evidence of bias in treatment effect estimates in controlled trials with different interventions and outcomes: meta-epidemiological study. BMJ 2008;336:601-5.
Wulf 2008